Novo CEO pressed by Senate to cut selling prices of being overweight, diabetes medications CEO Lars Fruergaard Jørgensen instructed lawmakers the company would contemplate new talks with insurers with regards to the list rates of Wegovy and copyright whenever they pledge to maintain the medicines on their own formularies. Never https://kethek.com/